Medicus Pharma earnings were -$56.7M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest MDCX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$11.6M, up 28.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MDCX reported annual earnings of -$47.3M, with 323.8% growth.
On MDCX's earnings call on Aug 10, 2026, Medicus Pharma (NASDAQ: MDCX) reported Q2 2026 earnings per share (EPS) of -$0.21, up 51.16% year over year. Total MDCX earnings for the quarter were -$11.62 million. In the same quarter last year, Medicus Pharma's earnings per share (EPS) was -$0.43.
As of the last Medicus Pharma earnings report, Medicus Pharma is currently losing money. Medicus Pharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$44.89 million, a 162.63% increase year over year.
What was MDCX's earnings growth in the past year?
As of Medicus Pharma's earnings date in Aug 10, 2026, Medicus Pharma's earnings has grown year over year. MDCX earnings in the past year totalled -$56.66 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.